Search Results

Xeomin^®: an innovative new botulinum toxin type A

Author: Frevert, J.

Source: European Journal of Neurology, Volume 16, Supplement 2, December 2009 , pp. 11-13(3)

Publisher: Blackwell Publishing

Clinical efficacy and tolerability of Xeomin^® in the treatment of blepharospasm

Author: Jankovic, J.

Source: European Journal of Neurology, Volume 16, Supplement 2, December 2009 , pp. 14-18(5)

Publisher: Blackwell Publishing

Brain-derived neurotrophic factor and risk for primary adult-onset cranial-cervical dystonia

Authors: Martino, D.; Muglia, M.; Abbruzzese, G.; Berardelli, A.; Girlanda, P.; Liguori, M.; Livrea, P.; Quattrone, A.; Roselli, F.; Sprovieri, T.; Valente, E. M.; Defazio, G.

Source: European Journal of Neurology, Volume 16, Number 8, August 2009 , pp. 949-952(4)

Publisher: Blackwell Publishing

Pallidal deep brain stimulation in the treatment of Meige syndrome

Authors: Blomstedt, P.; Tisch, S.; Hariz, M. I.

Source: Acta Neurologica Scandinavica, Volume 118, Number 3, September 2008 , pp. 198-202(5)

Publisher: Blackwell Publishing

Increased basal-ganglia activation performing a non-dystonia-related task in focal dystonia

Authors: Obermann, M.; Yaldizli, O.; de Greiff, A.; Konczak, J.; Lachenmayer, M. L.; Tumczak, F.; Buhl, A. R.; Putzki, N.; Vollmer-Haase, J.; Gizewski, E. R.; Diener, H.-C.; Maschke, M.

Source: European Journal of Neurology, Volume 15, Number 8, August 2008 , pp. 831-838(8)

Publisher: Blackwell Publishing

Diffusion tensor imaging in patients with primary cervical dystonia and in patients with blepharospasm

Authors: Fabbrini, G.; Pantano, P.; Totaro, P.; Calistri, V.; Colosimo, C.; Carmellini, M.; Defazio, G.; Berardelli, A.

Source: European Journal of Neurology, Volume 15, Number 2, February 2008 , pp. 185-189(5)

Publisher: Blackwell Publishing

Shedding Light on Blepharospasm: A Patient-Researcher Partnership Approach to Assessment of Photophobia and Impact on Activities of Daily Living

Authors: Judd, Rebecca A.; Digre, Kathleen B.; Warner, Judith EA; Schulman, Susan F.; Katz, Bradley J.

Source: Neuro-Ophthalmology, Volume 31, Number 3, June 2007 , pp. 49-54(6)

Publisher: Informa Healthcare

Spread of primary dystonia in relation to initially affected region

Authors: Svetel, M.; Pekmezović, T.; Jović, J.; Ivanović, N.; Dragašević, N.; Marić, J.; Kostić, V.

Source: Journal of Neurology, Volume 254, Number 7, July 2007 , pp. 879-883(5)

Publisher: Springer

Glucose hypermetabolism in the thalamus of patients with essential blepharospasm

Authors: Suzuki, Y.; Mizoguchi, S.; Kiyosawa, M.; Mochizuki, M.; Ishiwata, K.; Wakakura, M.; Ishii, K.

Source: Journal of Neurology, Volume 254, Number 7, July 2007 , pp. 890-896(7)

Publisher: Springer

Ziprasidone: Blepharospasm with ocular dystonia: case report

Source: Reactions, Volume 1, Number 1177, 2007-11-10 , pp. 30-30(1)

Publisher: Adis International

Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson's disease

Authors: Sheffield, James K; Jankovic, Joseph

Source: Expert Review of Neurotherapeutics, Volume 7, Number 6, June 2007 , pp. 637-647(11)

Publisher: Expert Reviews

Peripheral Kynurenine Metabolism in Focal Dystonia

Authors: Hartai, Zsuzsanna; Klivenyi, Peter; Janaky, Tamas; Penke, Botond; Dux, Laszlo; Vecsei, Laszlo

Source: Medicinal Chemistry, Volume 3, Number 3, May 2007 , pp. 285-288(4)

Publisher: Bentham Science Publishers

Botulinum Neurotoxin Type A Free of Complexing Proteins (XEOMIN^®) in Focal Dystonia

Authors: Jost, Wolfgang H.; Blümel, Jörg; Grafe, Susanne

Source: Drugs, Volume 67, Number 5, 2007 , pp. 669-683(15)

Publisher: Adis International

Using AbilityMatch to identify potential work solutions for an employee with blepharospasm dystonia

Author: Wong, Georgina

Source: Journal of Occupational Psychology, Employment and Disability, Volume 8, Number 2, Autumn 2006 , pp. 183-192(10)

Publisher: DWP Occupational & Health Psychology Services

Clinical value of botulinum toxin in neurological indications

Authors: Ward, A. B.; Molenaers, G.; Colosimo, C.; Berardelli, A.

Source: European Journal of Neurology, Volume 13, Supplement 4, December 2006 , pp. 20-26(7)

Publisher: Blackwell Publishing

Levetiracetam in Meige's syndrome

Authors: Yardimci, N.; Karatas, M.; Kilinc, M.; Benli, S.

Source: Acta Neurologica Scandinavica, Volume 114, Number 1, July 2006 , pp. 63-66(4)

Publisher: Blackwell Publishing

Silent event-related fMRI reveals deficient motor and enhanced somatosensory activation in orofacial dystonia

Authors: Dresel, Christian; Haslinger, Bernhard; Castrop, Florian; Wohlschlaeger, Afra M.; Ceballos-Baumann, Andrés O.

Source: Brain, Volume 129, Number 1, January 2006 , pp. 36-46(11)

Publisher: Oxford University Press

A 9-year review of dystonia from a movement disorders clinic in Singapore

Authors: Jamora, R. D. G.; Tan, A. K. Y.; Tan, L. C. S.

Source: European Journal of Neurology, Volume 13, Number 1, January 2006 , pp. 77-81(5)

Publisher: Blackwell Publishing

The use of botulinum toxin type-B in the treatment of patients who have become unresponsive to botulinum toxin type-A – initial experiences

Authors: Barnes, M. P.; Best, D.; Kidd, L.; Roberts, B.; Stark, S.; Weeks, P.; Whitaker, J.

Source: European Journal of Neurology, Volume 12, Number 12, December 2005 , pp. 947-955(9)

Publisher: Blackwell Publishing

Long-term treatment with botulinum toxin is effective and is associated with a low incidence of immunogenicity

Source: Inpharma, Volume 1, Number 1494, 2005-07-02 , pp. 16-16(1)

Publisher: Adis International